---
figid: PMC9503112__ijms-23-10854-sch001
pmcid: PMC9503112
image_filename: ijms-23-10854-sch001.jpg
figure_link: /pmc/articles/PMC9503112/figure/ijms-23-10854-sch001/
number: Scheme 1
figure_title: ''
caption: 'Synthesis of 7-aryl-2,4-bis(morpholino)quinazoline 6. Reagents and conditions:
  a-SnCl2*2H2O, H2O-HCl (1:1), 90 °C; b-urea, 150 °C, no solvent; c-POCl3, Et3N, 95
  °C; d-morpholine, DCM, 0 °C → rt; e-N-Boc-protected p-aminophenylpinacolborane,
  Pd(PPh3)4, Na2CO3, 1,4-dioxane-H2O, 100 °C; f-TFA, DCM, rt.'
article_title: Synthesis, Molecular Docking, In Vitro and In Vivo Studies of Novel
  Dimorpholinoquinazoline-Based Potential Inhibitors of PI3K/Akt/mTOR Pathway.
citation: Maria V. Zapevalova, et al. Int J Mol Sci. 2022 Sep;23(18):10854.
year: '2022'

doi: 10.3390/ijms231810854
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- dimorpholinoquinazoline
- cancer
- PI3K/Akt/mTOR inhibitor
- S6K
- kinase inhibition activity

---
